INS and diabetes mellitus: A double-blind randomized clinical trial (RCT) concluded that participants who consumed a diabetes-specific formula—containing whey protein, medium-chain triglycerides (MCTs), a lower percentage of rapidly absorbed carbohydrates, and fiber—showed a statistically significant improvement in postprandial glycemia, and a non-significant reduction in insulin secretion, compared to patients receiving a standard formula.